SCHEMBL17225124

SCHEMBL17225124

O=C(ON(C(=O)O)S(=O)(=O)c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
ALOX15 P16050 1/20 0.52
TP53 P04637 1/20 0.51
TAS2R14 Q9NYV8 2/20 0.49
CXCR3 P49682 1/20 0.49
FLT1 P17948 1/20 0.47
FLT4 P35916 1/20 0.47
KDR P35968 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 3/20 0.46
DAGLA Q9Y4D2 1/20 0.44
POLB P06746 1/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA3 P07451 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18488891 0.83 MEN1 (0.48) MEN1KMT2AALOX15TP53TAS2R14
SCHEMBL1643247 0.80 MEN1 (0.79) MEN1KMT2AALOX15TP53TAS2R14
SCHEMBL1950189 0.73 ITGAV (0.40) KMT2AL3MBTL1MAPTSMN1; SMN2
SCHEMBL11603992 0.71 TP53 (0.55) MEN1KMT2ATP53TAS2R14CXCR3
SCHEMBL28058202 0.70 HSD11B1 (0.49) KMT2AL3MBTL1MAPTPOLBSMN1; SMN2
SCHEMBL31495844 0.70 TP53 (0.50) MEN1KMT2ATP53TAS2R14CXCR3
SCHEMBL1169742 0.70 TP53 (0.79) MEN1KMT2ATP53TAS2R14CXCR3
SCHEMBL1947890 0.69 MEN1 (1.00) MEN1KMT2AALOX15TP53MAPT
SCHEMBL11448337 0.69 HSD11B1 (0.51) MEN1KMT2ATP53TAS2R14CXCR3
Benzoyl Peroxide SCHEMBL10536706 0.68 LMNA (0.74) MEN1KMT2AALOX15TP53L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3137068-A1 TREATMENT OF FIBROSIS UCL Business Plc. (GB) 2017-03-08 EP disclosed
WO-2015166277-A1 TREATMENT OF FIBROSIS UCL BUSINESS PLC (GB) 2015-11-05 WO disclosed